Doxorubicin (Cristal Therapeutics)

N/A

Report date: 2026/01/26 13:50:12

Base Information

Drug NameDoxorubicin (Cristal Therapeutics)
Drug Alias NameDoxorubicinDoxorubicin (Cristal Delivery)CD-103
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionDNA intercalators
TargetsDNA
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCristal Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCristal Therapeutics
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A